• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4833721)   Today's Articles (5709)
For: Stevenson JC, Teter P, Lees B. 17beta-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women. Maturitas 2001;38:197-203. [PMID: 11306209 DOI: 10.1016/s0378-5122(00)00219-x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Number Cited by Other Article(s)
1
Zeng L, Gu R, Li W, Shao Y, Zhu Y, Xie Z, Liu H, Zhou Y. Ataluren prevented bone loss induced by ovariectomy and aging in mice through the BMP-SMAD signaling pathway. Biomed Pharmacother 2023;166:115332. [PMID: 37597324 DOI: 10.1016/j.biopha.2023.115332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 08/02/2023] [Accepted: 08/13/2023] [Indexed: 08/21/2023]  Open
2
Pickar JH, Archer DF, Goldstein SR, Kagan R, Bernick B, Mirkin S. Uterine bleeding with hormone therapies in menopausal women: a systematic review. Climacteric 2020;23:550-558. [PMID: 32893694 DOI: 10.1080/13697137.2020.1806816] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
3
Zhu SY, Deng Y, Wang YF, Xue W, Ma X, Sun A. Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail. Gynecol Endocrinol 2019;35:165-169. [PMID: 30449208 DOI: 10.1080/09513590.2018.1505849] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
4
Stevenson JC, Panay N, Pexman-Fieth C. Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas 2013;76:10-21. [PMID: 23835005 DOI: 10.1016/j.maturitas.2013.05.018] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Accepted: 05/27/2013] [Indexed: 10/26/2022]
5
Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012;2012:CD000402. [PMID: 22895916 PMCID: PMC7039145 DOI: 10.1002/14651858.cd000402.pub4] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
6
Bergeron C, Nogales FF, Rechberger T, Tatarchjuk T, Zipfel L. Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate. Maturitas 2010;66:201-5. [PMID: 20378287 DOI: 10.1016/j.maturitas.2010.03.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2009] [Revised: 02/25/2010] [Accepted: 03/08/2010] [Indexed: 11/27/2022]
7
Furness S, Roberts H, Marjoribanks J, Lethaby A, Hickey M, Farquhar C. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2009:CD000402. [PMID: 19370558 DOI: 10.1002/14651858.cd000402.pub3] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
8
Corrao G, Zambon A, Nicotra F, Conti V, Nappi RE, Merlino L. Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Br J Clin Pharmacol 2007;65:123-9. [PMID: 17953723 DOI: 10.1111/j.1365-2125.2007.02904.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]  Open
9
Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 2006;13:660-8. [PMID: 16837888 DOI: 10.1097/01.gme.0000227335.27996.d8] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
10
Quereux C, Pornel B, Bergeron C, Ferenczy A. Continuous combined hormone replacement therapy with 1mg 17β-oestradiol and 5mg dydrogesterone (Femoston®-conti): Endometrial safety and bleeding profile. Maturitas 2006;53:299-305. [PMID: 16043317 DOI: 10.1016/j.maturitas.2005.05.015] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2004] [Revised: 04/26/2005] [Accepted: 05/09/2005] [Indexed: 10/25/2022]
11
Stevenson JC. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 2005;51:113-26. [PMID: 15917151 DOI: 10.1016/j.maturitas.2005.01.012] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2004] [Accepted: 01/22/2005] [Indexed: 10/25/2022]
12
Arrenbrecht S, Caubel P, Garnero P, Felsenberg D. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women. Maturitas 2005;48:197-207. [PMID: 15207885 DOI: 10.1016/j.maturitas.2003.08.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2003] [Revised: 07/11/2003] [Accepted: 08/26/2003] [Indexed: 11/16/2022]
13
Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 2004;11:466-73. [PMID: 15243285 DOI: 10.1097/01.gme.0000109313.11228.2b] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
14
Lethaby A, Suckling J, Barlow D, Farquhar CM, Jepson RG, Roberts H. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2004:CD000402. [PMID: 15266429 DOI: 10.1002/14651858.cd000402.pub2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
15
Thijssen JHH. Overview on the effects of progestins on bone. Maturitas 2003;46 Suppl 1:S77-87. [PMID: 14670649 DOI: 10.1016/j.maturitas.2003.09.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
16
Coelingh Bennink HJT, Boerrigter PJ. Use of dydrogesterone as a progestogen for oral contraception. Steroids 2003;68:927-9. [PMID: 14667985 DOI: 10.1016/j.steroids.2003.07.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
17
Pornel B, Chevallier O, Netelenbos JC. Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women. Menopause 2002;9:171-8. [PMID: 11973440 DOI: 10.1097/00042192-200205000-00005] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA